Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease
Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease
Active, not recruiting · NCT04166565 · Registry updated 2026-04-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, extramedullary plasmacytoma, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-04-20 | NCT04166565 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen, LP | 23 |
| Stichting European Myeloma Network | 4 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ankara University | Ankara | Turkey (Türkiye) | 5 |
| Anticancer Hospital of Thessaloniki | Thessaloniki | Greece | 1 |
| Dokuz Eylul University | Balçova | Turkey (Türkiye) | 1 |
| Erciyes University | Kayseri | Turkey (Türkiye) | 7 |
| Marmara University | Pendik | Turkey (Türkiye) | 1 |
| Univerity of Turin | Torino | Italy | 1 |
| University of Athens | Athens | Greece | 2 |
| University of Bologna | Bologna | Italy | 6 |